Published in Acta Obstet Gynecol Scand Suppl on January 01, 1980
Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell (2009) 2.60
Serum iron, ferritin, transferrin, total iron binding capacity, hs-CRP, LDL cholesterol and magnesium in children; new reference intervals using the Dade Dimension Clinical Chemistry System. Clin Chim Acta (2004) 0.87
Accuracy of erythrogram and serum ferritin for the maternal anemia diagnosis (AMA): a phase 3 diagnostic study on prediction of the therapeutic responsiveness to oral iron in pregnancy. BMC Pregnancy Childbirth (2013) 0.79
Maternal Myocardial Performance in Second Trimester of Pregnancy With Iron Deficiency Anaemia. J Clin Diagn Res (2016) 0.75
Could the erythrocyte indices or serum ferritin predict the therapeutic response to a trial with oral iron during pregnancy? Results from the Accuracy study for Maternal Anaemia diagnosis (AMA). BMC Pregnancy Childbirth (2016) 0.75
Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ (1998) 1.96
Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer (1989) 1.83
Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab (1983) 1.79
Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) (2001) 1.74
Pregnenolone and its sulfate ester in the rat brain. Brain Res (1983) 1.57
Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol Metab (1987) 1.56
Neuromuscular adaptations and serum hormones in women during short-term intensive strength training. Eur J Appl Physiol Occup Physiol (1992) 1.50
Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts. Eur J Nucl Med (1991) 1.38
Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem (1984) 1.33
Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett (1988) 1.21
Clomiphene citrate administration to normogonadotropic subfertile men: blood hormone changes and activation of acid phosphatase in seminal fluid. Int J Androl (1981) 1.20
Serum hormones during prolonged training of neuromuscular performance. Eur J Appl Physiol Occup Physiol (1985) 1.19
Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Br J Cancer (1984) 1.12
Enhanced activity of the pituitary-gonadal axis in premature human infants. J Clin Endocrinol Metab (1981) 1.11
Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women. J Appl Physiol (1985) (2001) 1.10
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared. Cancer (1985) 1.10
Analysis of multiple casualty incidents - a prospective cohort study. Acta Anaesthesiol Scand (2005) 1.09
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer (1985) 1.08
Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab (1996) 1.08
Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer (1996) 1.08
Acute hormonal responses to two different fatiguing heavy-resistance protocols in male athletes. J Appl Physiol (1985) (1993) 1.06
Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women. J Gerontol A Biol Sci Med Sci (2000) 1.06
Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol Endocrinol (1998) 1.05
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab (1990) 1.04
Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol (Oxf) (1985) 1.03
Neuromuscular and hormonal adaptations in athletes to strength training in two years. J Appl Physiol (1985) (1988) 1.02
Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med (1995) 1.01
Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum Genet (1994) 1.01
Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinol (Copenh) (1984) 1.00
Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels. Int J Cancer (1980) 1.00
Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands. Acta Endocrinol (Copenh) (1975) 0.99
The desmoid tumor. III. A biochemical and genetic analysis. Am J Clin Pathol (1982) 0.98
Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol (1981) 0.97
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer (1999) 0.97
Concentrations of androgens in human benign prostatic hypertrophic tissues incubated for up to three days. Prostate (1986) 0.96
Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis. J Steroid Biochem Mol Biol (1995) 0.96
Screening of bacteria in urine using luciferin-luciferase assay of microbial ATP: a comparative study. Ann Clin Biochem (1982) 0.96
Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration. Int J Cancer (1979) 0.96
Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res (1997) 0.95
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. Arterioscler Thromb Vasc Biol (1996) 0.95
DNA-dependent RNA polymerases I and II from kidney. Effect of polyamines on the in vitro transcription of DNA and chromatin. Biochemistry (1975) 0.95
Immunological analysis of 17 beta-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer (1992) 0.94
Effects of combined endurance and strength training on muscle strength, power and hypertrophy in 40-67-year-old men. Scand J Med Sci Sports (2009) 0.93
Hormonal pattern of adolescent menstrual cycles. J Clin Endocrinol Metab (1978) 0.93
Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue. Am J Obstet Gynecol (1981) 0.93
Follicular growth in relation to serum hormonal patterns in adolescent compared with adult menstrual cycles. Fertil Steril (1987) 0.92
Oestrogen-induced progesterone receptor in human uterus. J Steroid Biochem (1976) 0.92
Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes. J Steroid Biochem (1986) 0.92
Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia. Scand J Rheumatol (2005) 0.92
Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment. Acta Obstet Gynecol Scand Suppl (1984) 0.92
Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. Bone (2002) 0.91
Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med (1985) 0.91
Serum ferritin as a measure of iron stores during and after normal pregnancy with and without iron supplements. Acta Obstet Gynecol Scand Suppl (1980) 0.90
17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res (1992) 0.90
Origin of substrate specificity of human and rat 17beta-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions. Endocrinology (1997) 0.90
Circulating sex hormone-binding globulin and testosterone in newborns and infants. Clin Endocrinol (Oxf) (1989) 0.90
A method for identification and follow-up of patients with a steroid-21-hydroxylase deficiency. Clin Chim Acta (1979) 0.90
Relationships between training volume, physical performance capacity, and serum hormone concentrations during prolonged training in elite weight lifters. Int J Sports Med (1987) 0.89
Acute hormonal and neuromuscular responses and recovery to forced vs maximum repetitions multiple resistance exercises. Int J Sports Med (2003) 0.89
Secretion of free and sulfate-conjugated neutral steroids by the human testis. Effect of administration of human chorionic gonadotropin. J Clin Endocrinol Metab (1971) 0.89
A systems model of training responses and its relationship to hormonal responses in elite weight-lifters. Eur J Appl Physiol Occup Physiol (1990) 0.89
Simultaneous determination of five sex hormones in human serum by radioimmunoassay after chromatography on Lipidex-5000. Clin Chem (1976) 0.88
Ectopic pregnancy--an analysis of the etiology, diagnosis and treatment in 552 cases. Arch Gynecol (1986) 0.88
Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol. Fertil Steril (1985) 0.88
Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med (1998) 0.88
Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose. Eur J Clin Pharmacol (1979) 0.88
Acute hormonal responses to heavy resistance exercise in men and women at different ages. Int J Sports Med (1995) 0.88
Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab (1995) 0.88
Regulation of cytosol and nuclear progesterone receptors in rabbit uterus by estrogen, antiestrogen and progesterone administration. Biochim Biophys Acta (1979) 0.88
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol (1987) 0.87
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer (1993) 0.87
Fingernail cystine of vanadium workers. Int Arch Occup Environ Health (1980) 0.87
17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat (1999) 0.87
Genomic organization and DNA sequences of human 17 beta-hydroxysteroid dehydrogenase genes and flanking regions. Localization of multiple Alu sequences and putative cis-acting elements. Eur J Biochem (1992) 0.87
Uterine and lung uteroglobins in the rabbit. Two similar proteins with differential hormonal regulation. Biochim Biophys Acta (1978) 0.87
Daily hormonal and neuromuscular responses to intensive strength training in 1 week. Int J Sports Med (1988) 0.87
Sex hormone-binding globulin--still many questions. Scand J Clin Lab Invest (1985) 0.87
Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol (2005) 0.87
Immunohistochemical localization of 17 beta-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest (1991) 0.87
Strength, [corrected] endurance or combined training elicit diverse skeletal muscle myosin heavy chain isoform proportion but unaltered androgen receptor concentration in older men. Int J Sports Med (2009) 0.87
The proximal promoter region of the gene encoding human 17beta-hydroxysteroid dehydrogenase type 1 contains GATA, AP-2, and Sp1 response elements: analysis of promoter function in choriocarcinoma cells. Endocrinology (1997) 0.86
Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type 1. J Endocrinol (1996) 0.86
The simultaneous radioimmunoassay of seven steroids in human spermatic and peripheral venous blood. J Clin Endocrinol Metab (1977) 0.86
Molecular cloning of mouse 17 beta-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. Eur J Biochem (1996) 0.86
Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells. Endocrinology (1993) 0.86
Serum prolactin, FSH and LH during puberty in girls and boys. Acta Paediatr Scand (1978) 0.85
Expression of 17beta-hydroxysteroid dehydrogenase type 1 and type 2, P450 aromatase, and 20alpha-hydroxysteroid dehydrogenase enzymes in immature, mature, and pregnant rats. Endocrinology (1997) 0.85
Characterization of structural and functional properties of human 17 beta-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis. Mol Endocrinol (1997) 0.85